Cargando…
Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients
Background: Despite improvement of tumor response rates, targeted therapy may induce toxicities in cancer patients. Recent studies indicate amelioration of adverse events (AEs) by add-on mistletoe (Viscum album L., VA) in standard oncological treatment. The primary objective of this multicenter obse...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164814/ https://www.ncbi.nlm.nih.gov/pubmed/30200590 http://dx.doi.org/10.3390/medicines5030100 |